Back to top
more

Tempus AI, Inc. (TEM)

(Delayed Data from NSDQ)

$72.69 USD

72.69
15,928,284

+6.04 (9.06%)

Updated Aug 21, 2026 04:00 PM ET

After-Market: $71.94 -0.75 (-1.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sridatri Sarkar headshot

TEM's Stable Solvency and Financial Strength Are Gaining Attention

by Sridatri Sarkar

Tempus AI posts a strong Q3 2025 balance sheet with $760M cash, no current debt, and positive adjusted EBITDA, boosting flexibility and solvency.

Debanjana Dey headshot

Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization

by Debanjana Dey

HIMS deepens its AI and data strategy with personalized care tools, biomarker tracking, and smarter treatment matching.

Sridatri Sarkar headshot

How Tempus AI Is Building Scale While Near-Term Risks Persist

by Sridatri Sarkar

TEM is scaling via growing multi-quarter bookings, but delayed revenue conversion, MRD competition and rising losses keep near-term risks in focus.

Sridatri Sarkar headshot

TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside

by Sridatri Sarkar

Tempus AI and Hims & Hers are riding healthcare IT growth, but diagnostics scale and consumer demand set different upside paths.

Sridatri Sarkar headshot

How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up

by Sridatri Sarkar

TEM sees modest Q3 reimbursement gains, but FDA and ADLT pathways for xT, xF and xR assays could narrow its pricing gap over 2025-2026.

Sridatri Sarkar headshot

Tempus AI Approaching Profitability Despite GAAP Losses

by Sridatri Sarkar

TEM shows early profitability inflection with first positive Adjusted EBITDA in Q3 2025, raised revenue guidance and disciplined spending despite GAAP losses.

Urmimala Biswas headshot

Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data

by Urmimala Biswas

Tempus AI posts first positive adjusted EBITDA as genomics testing accelerates and data bookings broaden. Zacks Rank #3 (Hold) with mixed Style Scores.

Debanjana Dey headshot

Hims & Hers Scales Technology-Driven Care as Profitability Evolves

by Debanjana Dey

HIMS scales personalized care, expands globally and invests in technology as it balances growth with evolving profitability.

Urmimala Biswas headshot

Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up

by Urmimala Biswas

Tempus AI's Q3 revenue surged as oncology and hereditary testing led the way, margins improved, and pricing tailwinds and regulatory milestones took shape.

Sridatri Sarkar headshot

3 MedTech Stocks Poised to Gain in 2026 From the AI Boom

by Sridatri Sarkar

AI is reshaping MedTech, and Stryker, Tempus AI and GE HealthCare are emerging as key players leveraging AI across surgery, diagnostics and imaging.